Silk'n FACETITE MULTIPLATFORM User Manual page 9

Table of Contents

Advertisement

Available languages
  • EN

Available languages

  • ENGLISH, page 1
• Have a history of skin cancer, or current condition of any other
EN
type of cancer or pre-malignant moles.
• Have received radiation therapy or chemotherapy treatments
within the past 3 months, or have areas of potential skin
malignancies.
• Have an impaired immune system due to immuno-suppressive
diseases such as AIDS and HIV, or using immuno-suppressive
medications.
• Have used Isotretinoin (Accutane
this product.
• Have a disease related to photosensitivity, such as porphyria, poly-
morphic light eruption, solar urticaria, lupus, etc.
• Suffer from epilepsy.
• Are pregnant or nursing.
DO NOT USE ON AREAS THAT HAVE:
• A permanent implant such as metal plates and screws (except oral
ones), silicone implants, or areas with injected fills or toxins.
• Any active condition in the areas using this product, such as sores,
psoriasis, eczema, rashes, open lacerations, abrasions, or lesions.
• purulent skin with inflammation, or history of keloid scars,
abnormal wound healing or skin vulnerability.
• Any piercings or other metallic (e.g. titanium) materials.
• Had any surgery within 3 months prior to using this product.
Seek medical advice before continued use, if you experience an unex-
pected side effect, such as itchy skin, within the first 48 hours of using
this product.
CONSULT YOUR PHYSICIAN IF YOU HAVE:
• Couperose or rosacea.
• A history of diseases stimulated by heat, such as recurrent herpes
simplex in the areas using this product. If so, you may use this
product following a prophylactic regimen.
• Used physician-prescribed drugs on your skin within the past
6 months.
• Skin diseases, keloids, or abnormal wound healing.
• Any other conditions which, in the opinion of your physician or
dermatologist, would make it unsafe to use this product.
9
) within 6 months prior to using
®

Advertisement

Table of Contents
loading

This manual is also suitable for:

H2501

Table of Contents